To decrease risks, viruses used for gene therapy are extensively engineered to incorporate safety features such as

A) the presence of virulence genes.
B) ensuring insertion in regions near oncogenes.
C) pseudotyping to alter tissue specificity.
D) alteration of the germ line.
E) ensuring deletions in regions near oncogenes.